Your search returned 3 results.

Sort
Results
1.
A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. MedStar authors:
  • Trivedi, Neel
PMID:
  • 29610115
Year: 2018
Citation:
  • Blood Advances. 2(7):762-768, 2018 Apr 10
Institution:
  • MedStar Washington Hospital Center
Department:
  • Hematology and Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Cheson BD, Khan N, Ramzi P, Skarbnik A, Trivedi N, Ujjani C, Wang H
2.
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors:
  • Kumar, Anjali S
PMID:
  • 26187751
Citation:
  • Lancet Oncology. 16(8):957-66, 2015 Aug.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Surgery/Colorectal Surgery
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Multicenter Study
  • Research Support, N.I.H., Extramural
Form of publication:
  • Journal Article
All authors:
  • Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG
3.
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
  • Rao, Suman
PMID:
  • 30620668
Year: 2019
Citation:
  • Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution:
  • Medstar Franklin Square Medical Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
Pages

Powered by Koha